Chewy's Continued Growth: Autoship as the Sales Engine
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy CHWY?
Source: Fool
- Customer Loyalty Growth: Chewy's customer-centric operations have successfully attracted a loyal consumer base, benefiting from a 9% annual growth in the U.S. pet industry since 2018, showcasing significant market potential.
- Autoship Program Success: Chewy's Autoship subscription program is projected to account for 83% of sales by 2025, becoming the company's 'sales engine,' with profitability increasing through its distribution network, driving gross margins from 20% in 2019 to 29% today.
- EBITDA Margin Improvement: Chewy's EBITDA margin has surged from -7% in 2019 to 3%, with management forecasting it to reach 10% in the future, indicating a substantial enhancement in profitability and increasing investment appeal.
- New High-Margin Growth Areas: Chewy is expanding into high-margin growth areas such as Chewy Vet Care clinics and advertising, which are expected to generate higher revenues and profits, further solidifying its market position.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CHWY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CHWY
Wall Street analysts forecast CHWY stock price to rise
20 Analyst Rating
17 Buy
3 Hold
0 Sell
Strong Buy
Current: 26.220
Low
42.00
Averages
47.06
High
52.00
Current: 26.220
Low
42.00
Averages
47.06
High
52.00
About CHWY
Chewy, Inc. is an e-commerce business geared toward pet products and services. The Company’s products consist of pet food and treats, pet supplies and pet medications, other pet-health products, and pet services. It serves its customers through its retail websites, and its mobile applications and focuses on delivering customer service, competitive prices, convenience, including Chewy’s Autoship subscription program, and a range of pet food, treats and supplies, and pet healthcare products and services. It partners with approximately 3,200 of the brands in the pet industry, and it creates and offers its own private brands. It owns a number of trademark registrations and applications in the United States and in foreign jurisdictions. These trademarks include American Journey, Blue Box Event, Careplus, Chewy, Chewy.com, Chewy Vet Care, Dr. Lyon’s, Frisco, Goody Box, Onguard, PetMD, PracticeHub, Tiny Tiger, True Acre Farms, Tylee’s, Vibeful, and The Zoo.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Beat: Chewy reported Q4 earnings that exceeded market expectations, indicating ongoing growth potential in the pet supplies market, although specific figures were not disclosed.
- Analyst Target Cuts: Analysts from BNP Paribas and Citizens have lowered their price targets for Chewy's stock, reflecting a cautious market outlook on the company's future growth, which may impact investor confidence.
- Stock Momentum Decline: Despite the earnings beat, Chewy's stock momentum has dipped, indicating market concerns about the company's future performance, potentially leading to short-term selling pressure from investors.
- Market Reaction Analysis: The combination of analyst target cuts and declining stock momentum could negatively affect Chewy's market performance, prompting investors to closely monitor the company's future strategic adjustments and market responses.
See More
- Chewy's Stock Performance: Chewy's shares have increased by 1.9% following the acquisition of Modern Animal.
- Acquisition Details: The acquisition of Modern Animal is expected to enhance Chewy's offerings in the pet care market.
See More

Chewy's Acquisition: Chewy has acquired Modern Animal, a veterinary care company, to enhance its offerings in the pet health sector.
Integrated Health Care Ecosystem: The acquisition aims to create a fully integrated health care ecosystem for pets, combining retail and veterinary services.
See More
- Acquisition of Modern Animal: Chewy (CHWY) has agreed to acquire Modern Animal to accelerate its clinical expansion and evolve into a fully integrated pet healthcare ecosystem, expected to add over $125 million in annualized revenue, significantly enhancing its market competitiveness.
- Store Expansion: This acquisition will scale Chewy Vet Care's footprint from 18 to 47 locations, with expectations of achieving EBITDA-dollar neutrality by 2026, thereby strengthening the company's presence in the pet healthcare market.
- Customer Sales Growth: The integration of Modern Animal is projected to drive a 15% to 20% increase in net sales per active customer, further boosting Chewy's revenue growth and customer loyalty in the pet healthcare sector.
- Share Repurchase Program: Chewy also announced a $500 million increase to its existing share repurchase program, reflecting confidence in the company's long-term strategy and strong free cash flow generation, demonstrating a disciplined approach to capital allocation.
See More
- Earnings Beat: Chewy achieved an 8.3% revenue growth in 2025 and anticipates an 8.5% growth midpoint for 2026, indicating strong performance in the pet care market that attracts long-term investors.
- EBITDA Margin Expansion: Management expects EBITDA margins to rise from 5.7% to between 6.6% and 6.8%, with a long-term goal of exceeding 10%, significantly enhancing profitability and competitive positioning.
- New Business Development: Chewy added 10 new Vet Care clinics in 2025, bringing the total to 18, which, along with its pharmacy and insurance offerings, enhances customer loyalty and drives sales growth.
- Private Label Investment: Following the successful launch of its
See More
- Revenue Growth Outlook: Chewy anticipates revenue growth to rise from 8.3% in 2025 to 8.5% in 2026, indicating strong momentum in market expansion and reinforcing its competitive position in the e-commerce sector.
- EBITDA Margin Expansion: Management expects EBITDA margins to increase from 5.7% to between 6.6% and 6.8%, with long-term projections exceeding 10%, reflecting effective execution in reducing operating costs and introducing higher-margin products.
- Vet Care Clinics Expansion: Chewy added 10 Vet Care clinics in 2025, bringing the total to 18, which not only enhances customer loyalty but also drives sales through its pet pharmacy and insurance offerings, attracting more customers.
- Autoship Business Growth: Chewy's Autoship business accounted for 84% of net sales in Q4, up from 80.6% at the end of 2024, improving inventory management predictability while reducing overall shipping costs, thereby enhancing operating margins.
See More










